Deleterious effects of phosphate on vascular and endothelial function via disruption to the nitric oxide pathway-Reference-Cited by-同舟云学术

Deleterious effects of phosphate on vascular and endothelial function via disruption to the nitric oxide pathway

Published:2016-07-21 Issue: Volume: Page:gfw252
ISSN:0931-0509
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:Nephrol. Dial. Transplant.

Author:

Stevens Kathryn K.,Denby Laura,Patel Rajan K.,Mark Patrick B.,Kettlewell Sarah,Smith Godfrey L.,Clancy Marc J.,Delles Christian,Jardine Alan G.

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/doi/10.1093/ndt/gfw252/10860208/gfw252.pdf

Reference46 articles.

1. Prevalence of subclinical atheromatosis and associated risk factors in chronic kidney disease: the NEFRONA study

2. Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients;Ganesh;J Am Soc Nephrol,2001

3. Serum Phosphate Levels and Mortality Risk among People with Chronic Kidney Disease

4. Left Ventricular Hypertrophy: Is Hyperphosphatemia among Dialysis Patients a Risk Factor?

5. Kidney Disease and Cardiovascular Risk

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Lanthanum Carbonate on Serum Phosphate, Oxidative Stress, and Vascular Dysfunction in CKD;Kidney360;2024-05-23

2. Dietary Magnesium Intake and Proteinuria: Is There a Relationship?;Biological Trace Element Research;2023-12-19

3. Progress in pharmacotherapy for the treatment of hyperphosphatemia in renal failure;Expert Opinion on Pharmacotherapy;2023-08-11

4. Phosphate Control in Peritoneal Dialysis Patients: Issues, Solutions, and Open Questions;Nutrients;2023-07-16

5. Urinary phosphate is associated with cardiovascular disease incidence;Journal of Internal Medicine;2023-06-26